0000885590-12-000034.txt : 20120530 0000885590-12-000034.hdr.sgml : 20120530 20120530165158 ACCESSION NUMBER: 0000885590-12-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120525 FILED AS OF DATE: 20120530 DATE AS OF CHANGE: 20120530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAUL LAURENCE E CENTRAL INDEX KEY: 0001190966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 12878217 MAIL ADDRESS: STREET 1: LAURE CROWN VENTURE 1620 26TH ST STREET 2: SOUTH TOWER SUITE 300 CITY: SANTA MONICA STATE: CA ZIP: 90404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-05-25 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001190966 PAUL LAURENCE E 4787 LEVY ROAD MONTREAL A8 H4R 2P9 QUEBEC, CANADA 1 0 0 0 Common Shares, no par value 2012-05-25 4 P 0 5000 48.6 A 47397 D Common Shares, no par value 2012-05-29 4 P 0 700 48 A 48097 D This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1. by: Nicholas Zanoni for Laurence Paul 2012-05-30